Abstract

Background: Obesity is a multifactorial metabolic disorder characterized by the accumulation of excess energy in adipose tissue. The risk of this disorder lies in genetic problems, intake problems, psychological disorders, lack of exercise, eating habits, and medical conditions. Weight loss attempts involving dietary changes, behavioral modifications, and exercise have been of limited benefit to most affected individuals. Weight loss operations have obviously evolved in recent years. The most commonly used and best-studied procedure is laparoscopic sleeve gastrectomy (LSG). Aim: The aim of this study was to assess certain points of LSG (benefits and complications for patients with morbid obesity) performed in Al-Imamein Al-Kadhimein Medical City. Patients and Methods: Data were collected in a prospective cohort study in Al-Imamein Al-Kadhimein Medical City between January 2021 and December 2022. LSG was performed for 40 patients for the treatment of obesity and included the following demographic data: body mass index (BMI, weight in kilograms divided by height in square meters (kg/m2)), hip circumference, waist circumference, total cholesterol, triglyceride, low-density lipoprotein, high-density lipoprotein, HbA1c%, and fasting blood sugar, presence of comorbidity (e.g. diabetes and hypertension), and complications following surgery. All patients were followed 3 months and 9 months postoperatively. Results: A total of 40 obese patients underwent bariatric surgery (laparoscopic sleeve gastrectomy), there were 65% female and 35% male, their mean age was 34.30 ± 5.31 years (range:23-45 years), the mean weight of patients was 146.70 ± 21.92 kg (115- 200 kg), the mean BMI was 51.45 ± 5.65 kg/m2 (37.5-63.8 kg/m2). Excess weight loss was 69% after 9 months. The improvement in comorbid diseases was significant. Conclusion: LSG is a useful procedure for the surgical management of morbid obesity. Most people who underwent these operations experienced a reduction in complications of obesity, such as hypertension and diabetes mellitus.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.